Targeting pyruvate dehydrogenase kinase 1 overcomes EGFR C797S mutation-driven osimertinib resistance in non-small cell lung cancer.

Park W, Wei S, Xie CL, Han JH, Kim BS, Kim B, Jin JS, Yang ES, Cho MK, Ryu D, Yang HX, Bae SJ, Ha KT
Exp Mol Med. 2024 May;56(5):1137-1149. doi: 10.1038/s12276-024-01221-2. Epub 2024 May 1. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.